The adaptor protein NTAL enhances proximal signaling and potentiates corticosteroid-induced apoptosis in T-ALL

Experimental Hematology

Volumn 40, Issue 5, 2012, Pages 379-385

  Svojgr, Karel ^a,b   Kalina, Tomas ^a,b   Kanderova, Veronika ^a,b   Skopcova, Tereza ^c   Brdicka, Tomas ^c   Zuna, Jan ^a,b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^c INSTITUTE OF MOLECULAR GENETICS   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; CD69 ANTIGEN; METHYLPREDNISOLONE; MITOGEN ACTIVATED PROTEIN KINASE 1; NON T CELL ACTIVATION LINKER PROTEIN; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BLAST CELL; CASE REPORT; CELL STIMULATION; CHEMOSENSITIVITY; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL LINE; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; T CELL ACUTE LYMPHOBLASTIC LEUKEMIA;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; APOPTOSIS; BUTADIENES; DRUG RESISTANCE, NEOPLASM; HUMANS; JURKAT CELLS; LECTINS, C-TYPE; MAP KINASE SIGNALING SYSTEM; METHYLPREDNISOLONE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEOPLASM PROTEINS; NITRILES; PHOSPHORYLATION; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROTEIN KINASE INHIBITORS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTORS, ANTIGEN, T-CELL;

EID: 84859721528     PISSN: 0301472X     EISSN: 18732399     Source Type: Journal    
DOI: 10.1016/j.exphem.2012.01.011     Document Type: Article

References (16)

1. Stary J., Jabali Y., Trka J., et al. Long-term results of treatment of childhood acute lymphoblastic leukemia in the Czech Republic. Leukemia 2010, 24:425-428.
2. Riehm H., Reiter A., Schrappe M., et al. [Corticosteroid-dependent reduction of leukocyte count in blood as a prognostic factor in acute lymphoblastic leukemia in childhood (therapy study ALL-BFM 83)]. Klin Padiatr 1987, 199:151-160.
3. Svojgr K., Burjanivova T., Vaskova M., et al. Adaptor molecules expression in normal lymphopoiesis and in childhood leukemia. Immunol Lett 2009, 122:185-192.
4. Bellavia D., Campese A.F., Checquolo S., et al. Combined expression of pTalpha and Notch3 in T cell leukemia identifies the requirement of preTCR for leukemogenesis. Proc Natl Acad Sci U S A 2002, 99:3788-3793.
5. Talora C., Campese A.F., Bellavia D., et al. Pre-TCR-triggered ERK signalling-dependent downregulation of E2A activity in Notch3-induced T-cell lymphoma. EMBO Rep 2003, 4:1067-1072.
6. Horejsi V., Zhang W., Schraven B. Transmembrane adaptor proteins: organizers of immunoreceptor signalling. Nat Rev Immunol 2004, 4:603-616.
7. Brdicka T., Imrich M., Angelisova P., et al. Non-T cell activation linker (NTAL): a transmembrane adaptor protein involved in immunoreceptor signaling. J Exp Med 2002, 196:1617-1626.
8. Stork B., Engelke M., Frey J., et al. Grb2 and the non-T cell activation linker NTAL constitute a Ca(2+)-regulating signal circuit in B lymphocytes. Immunity 2004, 21:681-691.
9. Zhu M., Koonpaew S., Liu Y., et al. Negative regulation of T cell activation and autoimmunity by the transmembrane adaptor protein LAB. Immunity 2006, 25:757-768.
10. Janssen E., Zhu M., Zhang W., Koonpaew S., Zhang W. LAB: a new membrane-associated adaptor molecule in B cell activation. Nat Immunol 2003, 4:117-123.
11. Janssen E., Zhu M., Craven B., Zhang W. Linker for activation of B cells: a functional equivalent of a mutant linker for activation of T cells deficient in phospholipase C-gamma1 binding. J Immunol 2004, 172:6810-6819.
12. Chambard J.C., Lefloch R., Pouyssegur J., Lenormand P. ERK implication in cell cycle regulation. Biochim Biophys Acta 2007, 1773:1299-1310.
13. Teixeiro E., Daniels M.A. ERK and cell death: ERK location and T cell selection. FEBS J 2010, 277:30-38.
14. Daniels M.A., Teixeiro E., Gill J., et al. Thymic selection threshold defined by compartmentalization of Ras/MAPK signalling. Nature 2006, 444:724-729.
15. Hobbs S., Jitrapakdee S., Wallace J.C. Development of a bicistronic vector driven by the human polypeptide chain elongation factor 1alpha promoter for creation of stable mammalian cell lines that express very high levels of recombinant proteins. Biochem Biophys Res Commun 1998, 252:368-372.
16. Gregorj C., Ricciardi M.R., Petrucci M.T., et al. ERK1/2 phosphorylation is an independent predictor of complete remission in newly diagnosed adult acute lymphoblastic leukemia. Blood 2007, 109:5473-5476.